Skip to content
  • Features
  • FAQs
  • Clinicians
  • Research
  • About Us
  • Contact Us
  • Investors
  • Features
  • FAQs
  • Clinicians
  • Research
  • About Us
  • Contact Us
  • Investors
Support
Login
  • Features
  • Clinicians
  • FAQs
  • Research
  • Investor Centre
  • About Us
  • Contact Us
  • Login
  • Features
  • Clinicians
  • FAQs
  • Research
  • Investor Centre
  • About Us
  • Contact Us
  • Login

Author: Sean Bryceland

  • NewsVideos

Meet the Incoming CEO Webinar

JACC Advances: An Artificial Intelligence Algorithm for Detection of Severe Aortic Stenosis: A Clinical Cohort Study

Early Warning and Enhanced Detection for Heart Disease Webinar

Echo IQ’s Aortic Stenosis Phenotype | Dr David Playford

Investor Briefing and Webinar | Echo IQ (ASX:EIQ)

Enhanced detection of severe aortic stenosis via artificial intelligence: a clinical cohort study

MST Access commences coverage of Echo IQ

Echo IQ on Channel 9: How AI is Helping with Life Threatening Heart Diagnoses

AI potentially detects 72% more heart disease patients

Hydrix to sell AI technology that improves identification of structural heart disease

#aiwithheart
Linkedin X-twitter Youtube

EchoSolv™

  • Features
  • Pricing
  • FAQs
  • Research

Support

  • Login
  • Support Centre
  • API Docs

Company

  • About
  • News
  • Investor Centre
  • Contact Us

Legal

  • Policies
  • Privacy Policy
  • Security

ECHO IQ LIMITED

Address: Level 11, 66 Clarence Street, Sydney NSW 2000, Australia. Phone: +61 (0) 2 9159 3719. ABN 48 142 901 353.

© Copyright 2025 Echo IQ Limited. All rights reserved.